News AZITRAPAR

Equities

AZTR

US05479L1044

Market Closed - Nyse Other stock markets 01:40:00 28/06/2024 am IST			5-day change	1st Jan Change
0.132 ^USD	+12.72%		-7.30%	-85.65%

16/06	Certain Options of Azitra, Inc. are subject to a Lock-Up Agreement Ending on 16-JUN-2024.	CI
16/06	Certain Warrants of Azitra, Inc. are subject to a Lock-Up Agreement Ending on 16-JUN-2024.	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Azitra, Inc. Announces Reverse Stock Split	28/06	BU
Certain Options of Azitra, Inc. are subject to a Lock-Up Agreement Ending on 16-JUN-2024.	16/06	CI
Certain Warrants of Azitra, Inc. are subject to a Lock-Up Agreement Ending on 16-JUN-2024.	16/06	CI
Certain Common Stock of Azitra, Inc. are subject to a Lock-Up Agreement Ending on 16-JUN-2024.	16/06	CI
Azitra, Inc. Announces Presentation at the 2024 BIO International Convention	03/06	AQ
Azitra, Inc. Announces Presentation at the 2024 BIO International Convention	31/05	BU
Azitra Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting	20/05	AQ
Azitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting	17/05	BU
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting	13/05	AQ
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting	10/05	BU
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting	10/05	CI
Azitra, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05	CI
Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates	10/05	BU
Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting	23/04	BU
Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting	23/04	CI
Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024	19/04	BU
Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates	16/03	BU
Azitra, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	16/03	CI
Azitra Closes $5 Million Public Offering	17/02	MT
Azitra, Inc. Announces Closing of Public Offering	17/02	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News AZITRAPAR

Equities

AZTR

US05479L1044

Summary

Filters